Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06141135 · ClinicalTrials.gov registry record · NA

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

A NA study of Infertility, Female, sponsored by Genomic Prediction.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT06141135 is a NA study of Infertility, Female that is actively recruiting participants, run by Genomic Prediction. The registered enrollment target is 240 participants, below the 370-participant average among 18 other Infertility, Female trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06141135, a NA study of Infertility, Female, is actively recruiting participants, sponsored by Genomic Prediction.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Conditions Studied

Interventions

  • OTHER Preimplantation genetic testing for aneuploidy (PGTA)

Study Locations (1)

Massachusetts

  • Boston IVF - Waltham

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2023-11-15
Est. Completion 2026-11-15
Phase NA

Sponsor

Genomic Prediction

6 total trials

What the Registry Record Tells You About NCT06141135

The ClinicalTrials.gov registry entry for NCT06141135 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 370-participant average among 18 other Infertility, Female trials with a reported enrollment target (35% lower). The listed sponsor is Genomic Prediction, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility, Female appearing as the primary indexed condition, and to 1 intervention - of which Preimplantation genetic testing for aneuploidy (PGTA) is the first listed.

NCT06141135 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06141135 about?

NCT06141135 is a clinical study titled "GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial". The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

What is the current status of trial NCT06141135?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-11-15. Estimated completion is 2026-11-15.

What conditions does trial NCT06141135 study?

This clinical trial studies the following conditions: Infertility, Female.

What interventions are being tested in trial NCT06141135?

The interventions under investigation include: Preimplantation genetic testing for aneuploidy (PGTA) (OTHER).

Who is sponsoring clinical trial NCT06141135?

This trial is sponsored by Genomic Prediction, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06141135 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility, Female

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.